Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

Similar articles for PubMed (Select 11885597)

1.

NHEJ deficiency and disease.

Pierce AJ, Jasin M.

Mol Cell. 2001 Dec;8(6):1160-1.

2.

The embryonic lethality in DNA ligase IV-deficient mice is rescued by deletion of Ku: implications for unifying the heterogeneous phenotypes of NHEJ mutants.

Karanjawala ZE, Adachi N, Irvine RA, Oh EK, Shibata D, Schwarz K, Hsieh CL, Lieber MR.

DNA Repair (Amst). 2002 Dec 5;1(12):1017-26.

PMID:
12531011
3.
4.

Reduced repair of DNA double-strand breaks by homologous recombination in a DNA ligase I-deficient human cell line.

Goetz JD, Motycka TA, Han M, Jasin M, Tomkinson AE.

DNA Repair (Amst). 2005 Jun 8;4(6):649-54. Epub 2005 Apr 7.

PMID:
15907772
5.

Tetramerization and DNA ligase IV interaction of the DNA double-strand break repair protein XRCC4 are mutually exclusive.

Modesti M, Junop MS, Ghirlando R, van de Rakt M, Gellert M, Yang W, Kanaar R.

J Mol Biol. 2003 Nov 21;334(2):215-28.

PMID:
14607114
6.

Loss of DNA ligase IV prevents recognition of DNA by double-strand break repair proteins XRCC4 and XLF.

Jayaram S, Ketner G, Adachi N, Hanakahi LA.

Nucleic Acids Res. 2008 Oct;36(18):5773-86. doi: 10.1093/nar/gkn552. Epub 2008 Sep 9.

7.

DNA ligase III as a candidate component of backup pathways of nonhomologous end joining.

Wang H, Rosidi B, Perrault R, Wang M, Zhang L, Windhofer F, Iliakis G.

Cancer Res. 2005 May 15;65(10):4020-30.

8.

Genetic interactions between BLM and DNA ligase IV in human cells.

So S, Adachi N, Lieber MR, Koyama H.

J Biol Chem. 2004 Dec 31;279(53):55433-42. Epub 2004 Oct 26.

9.

Low levels of DNA ligases III and IV sufficient for effective NHEJ.

Windhofer F, Wu W, Iliakis G.

J Cell Physiol. 2007 Nov;213(2):475-83.

PMID:
17492771
10.

Ligase IV syndrome.

Chistiakov DA, Voronova NV, Chistiakov AP.

Eur J Med Genet. 2009 Nov-Dec;52(6):373-8. doi: 10.1016/j.ejmg.2009.05.009. Epub 2009 May 23. Review.

PMID:
19467349
11.

Let's stick together.

Greenwood E.

Nat Rev Cancer. 2002 Feb;2(2):78-9. No abstract available.

PMID:
12635166
12.

XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining.

Ahnesorg P, Smith P, Jackson SP.

Cell. 2006 Jan 27;124(2):301-13.

14.

Replication failure, genome instability, and increased cancer susceptibility in mice with a point mutation in the DNA ligase I gene.

Harrison C, Ketchen AM, Redhead NJ, O'Sullivan MJ, Melton DW.

Cancer Res. 2002 Jul 15;62(14):4065-74.

15.

Human severe combined immune deficiency and DNA repair.

Schwarz K, Ma Y, Pannicke U, Lieber MR.

Bioessays. 2003 Nov;25(11):1061-70. Review.

PMID:
14579247
16.

DNA ligase I null mouse cells show normal DNA repair activity but altered DNA replication and reduced genome stability.

Bentley DJ, Harrison C, Ketchen AM, Redhead NJ, Samuel K, Waterfall M, Ansell JD, Melton DW.

J Cell Sci. 2002 Apr 1;115(Pt 7):1551-61.

17.

Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage.

Adachi N, Iiizumi S, So S, Koyama H.

Biochem Biophys Res Commun. 2004 Jun 11;318(4):856-61.

PMID:
15147950
18.

The non-homologous end-joining pathway is not involved in the radiosensitization of mammalian cells by heat shock.

Dynlacht JR, Bittner ME, Bethel JA, Beck BD.

J Cell Physiol. 2003 Sep;196(3):557-64.

PMID:
12891712
19.

Length-dependent binding of human XLF to DNA and stimulation of XRCC4.DNA ligase IV activity.

Lu H, Pannicke U, Schwarz K, Lieber MR.

J Biol Chem. 2007 Apr 13;282(15):11155-62. Epub 2007 Feb 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk